about
The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico.Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1The hepatitis C cascade of care: identifying priorities to improve clinical outcomesCost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States.The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients.Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programsThe cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United StatesThe cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trialReview of complications in a series of patients with known gastro-esophageal varices undergoing transesophageal echocardiography.Monetary conversion factors for economic evaluations of substance use disorders.Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings.Comparing academic and community-based hospitalists.Cost-Effectiveness Analysis of Probiotic Use to Prevent Clostridium difficile Infection in Hospitalized Adults Receiving Antibiotics.Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learned.Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs.Closing the gaps in opioid use disorder research, policy and practice: conference proceedingsOptimising the care of patients with cirrhosis and gastrointestinal haemorrhage: a quality improvement studyCost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid RelapseCriminal justice measures for economic data harmonization in substance use disorder researchCost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment ProgramsCost of pharmacotherapy for opioid use disorders following inpatient detoxification
P50
Q30842836-7F823CC5-5E38-4955-B3CA-CA85AB2C033AQ33629561-21955876-2C34-4B1F-95F3-4E316AE06D90Q33632459-F15BEBA1-F296-495B-924B-678928E5C149Q33688664-22D7C090-EAB2-4EB1-9D18-43524188B4D1Q33710740-7A4423F3-B40F-4A6C-9D77-ED348BA4DD27Q34735072-42437A0F-6FC2-4240-9C5D-4F5FA96EAC69Q35216253-DB8D13F0-4562-493E-977E-4B892A41B8C6Q35572125-9BAC4EF4-3BCB-4CC7-9998-2134B67E2D3DQ35726267-E9F5463F-297A-4A64-8C75-BA50F41377ADQ36536506-9CFAA042-0427-4C94-89DE-F0E948D7B52DQ37397359-2159A081-4FD6-4E94-A54D-17AB19645527Q38605382-A7AC2998-54F6-4426-9131-3F49BA00EC9AQ40112906-15FFD19D-7EDE-40C1-9C64-F2D7A0A65909Q41919051-332DB18C-52D7-462E-B836-9B36D480169DQ46558188-0B01EF48-FA3B-42AD-A27D-73D529CC5B2EQ47136286-918C5251-0CE1-4BFE-ADFB-7A1FE554D07AQ52646762-EF21A291-73D3-4A80-9445-95933B7FF45AQ52686909-6891571B-CF3A-4DA6-BDD8-6D25411A9890Q59340637-5D01838A-4A2E-407B-AF16-F249F756ABDFQ84129066-7C210BEF-B9BC-4FFC-97D3-CD94A5D5FA27Q90585028-0A9691EB-53CB-4C45-9B7F-5168F23A2FCDQ91642545-F8B2F5CE-29F2-4B97-9CAC-EF7D81A974ADQ92075679-C35715B7-4AF6-4D0E-87D7-90EF719A8131Q93210110-A11AF546-AAFE-4850-AF26-A5D8ABC1F90D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jared Leff
@ast
Jared Leff
@en
Jared Leff
@es
Jared Leff
@nl
Jared Leff
@sl
type
label
Jared Leff
@ast
Jared Leff
@en
Jared Leff
@es
Jared Leff
@nl
Jared Leff
@sl
prefLabel
Jared Leff
@ast
Jared Leff
@en
Jared Leff
@es
Jared Leff
@nl
Jared Leff
@sl
P1053
B-7631-2014
P106
P21
P31
P3829
P496
0000-0001-6995-6009